Rana Atique Anwer, Sajid Ghafor, Huma Ahmad. 2022. “Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer”. Pakistan Journal of Medical & Health Sciences 16 (08):356. https://doi.org/10.53350/pjmhs22168356.